Onderstepoort Biological Products SOC Ltd (OBP) stated that is aware of the growing concerns relating to the current shortage and unavailability of the African horse sickness (AHS) vaccine. The company is an entity of the Department of Agriculture, Land Reform and Rural Development.
In the statement by communication officer Zipho Linda on behalf of the company, the company said that facilities and equipment strategy, which comprise of short, medium, and long-term repairs, augmentation and replacements, are currently underway. In this regard, scheduled short-term repairs and maintenance are ongoing.
“The breakdown in some of our equipment has resulted in an interruption in the production of certain products, including the AHS vaccine. Contingency plans are being implemented and closely monitored to ensure that production outputs meet the demand. The company wishes to reassure the equine industry that all efforts are being made to ensure that the vaccine is available early in December,” the company said.
The company added that it takes cognisance of the apprehension caused in the market as a result of its product unavailability, but wishes to assure customers and stakeholders that it remains steadfast in its commitment and support in securing the safety of the equine population.
Post your comments on our Facebook Page at Sandton Chronicle.
ALSO READ:
Local horse rider makes a comeback of note at major competition
